alt gölge
Haberler
ABD'den Gelen "İlik" ile Hayat Buldu

ABD'den Gelen "İlik" ile Hayat Buldu 18 Ağustos 2016 Perşembe 11:01 Antalya'da 3 aylıkken immün yetmezliği teşhisi konulan 8 yaşındaki Yakup Akbalık, ABD'den gelen ilikle hayat buldu. SÜLEYMAN ELÇİN -  .....

Yurt İçinden Akraba Dışı Kordon Kanı Nakli Yapıldı

08 Ekim 2013 11:53 Haberler                           AA         Hatay'da yaşayan, immün yetmezliği nedeniyle yaşaması için kemik iliği nakli yapılması gereken 19 aylık Hatice bebeğe Türkiye'de ilk kez .....

tümünü göster »

ÖZGEÇMİŞ VE ESERLER LİSTESİ

Adı Soyadı
Mehmet Akif Yeşilipek
Doğum Tarihi
26.09.1956
Doğum Yeri
Niğde
Medeni Durumu
Evli, İki çocuklu
Prof.Dr. M.Akif YEŞİLİPEK
Öğrenim Durumu
DereceBölüm/ProgramÜniversiteYıl
LiseDeneme FenErzurum Lisesi1973
Lisans/Y. LisansTıp DoktorluğuHacettepe Üniversitesi Samsun Tıp Fakültesi1980
Tıpta Uzmanlık Çocuk Sağlığı ve HastalıklarıOndokuzmayıs Üniversitesi Tıp Fakültesi1984
Yan Dal UzmanlıkPediatrik Hematoloji Akdeniz Üniversitesi Tıp Fakültesi 2002
Görevler
Görev ÜnvanıGörev YeriYıl
Araş.Gör.Ondokuzmayıs Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı1980-1984
Uzm. Dr.Doğum ve Çocuk Hastanesi , Samsun1985-1989
Yard. Doç. Akdeniz Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı1989-1993
Doç. DrAkdeniz Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı1993-1999
Prof. Dr.Akdeniz Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı1999-2013
Prof. Dr. Bahçeşehir Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı2013-2017
Prof.Dr.Medicalpark Antalya ve İstanbul Göztepe Hastaneleri Pediatrik Hematoloji ve Çocuk Kemik İliği Nakil Ünitesi Bşk.2011-
İdari ve Akademik Görevler
Akdeniz Üniversitesi Hastanesi Başhekim Yardımcılığı1993-1996
Pediatrik Hematoloji Bilim Dalı Başkanlığı1993-2012
Kurucu Başkan
Çocuk Kök Hücre Transplantasyon Ünitesi Sorumluluğu1998-2012
Kurucu Başkan
Çocuk Sağlığı ve Hastalıkları Anabilim Dalı Başkanlığı2002-2008
Akdeniz Üniversitesi Talasemi Ünitesi Başkanlığı1996-2013
Türk Pediatrik Hematoloji Derneği Başkanlığı2009-2011
Sağlık Bakanlığı Kök Hücre Bilim Kurulu Üyeliği2008-2012
Sağlık Bakanlığı Hemoglobinopati Bilim Kurulu Üyeliği2010-2015
Tıpta Uzmanlık Kurulu Çocuk Hematolojisi ve Onkolojisi Komisyon Üyesi2009-2013
TÜBA Kök Hücre Bilim Kurulu2016-2018
Bilimsel ve Meslek Kuruluşlarına Üyelikler
1. Türk Pediatrik Hematoloji Derneği Yönetim Kurulu Üyeliği2001-2011
2. Türkiye Milli Pediatri Derneği Yönetim Kurulu Üyeliği2004-2009
3. Türkiye Milli Pediatri Derneği, Antalya Şube Başkanlığı2009-
4. Akdeniz Hemofili Derneği Yönetim Kurulu (Kurucu) Başkanlığı2005-2017
5. Antalya Çocuk Sağlığı Derneği Yönetim Kurulu Başkanlığı1998-2014
6. Akdeniz Talasemi Derneği II. Başkanlığı1995-2010
7. Akdeniz Talasemi Derneği Başkanlığı2010-
8. Türk Hematoloji Derneği Üyeliği
9. Türk Tabipleri Birliği Üyeliği
Uluslararası Bilimsel Kuruluşlara Üyelikler
1. Europan Group for Blood and Bone Marrow Transplantation (EBMT)
2. American Society of Hematology (ASH)
3. European Hematology Association (EHA)
Uluslararası İdari Görev
EBMT Pediatric Diseases Working Party Board üyeliği2014-
Görev aldığı Uluslararası Projeler
1. NOVAe-MED -an European Project of a New Generation; Innovative e-learning in reparative medicine, European Union Leonardo da Vinci Pilot Projects, BG/05/B/F/PP-166046, B tipi projede “Project Governing Committee” de bölüm sorumluluğu, 2005. http://novae-med.bg-id.com (6.Çerçeve Programı).
2. ALL-BFM Stem Cell Transplantation, EBMT Pediatric Disease Working Party Uluslararası çok merkezli prospektif çalışma, Türkiye Koordinatörü
3. LA-35 PM; Active Drug Surveillance Program for Ferriprox, principal investigator.
4. CORDELIA Cardiac Iron Overload Prevalence, principal investigator,
5. CICL670A2206, Defrasirox, Demir Şelasyon Tedavisi Etkinlik ve Güvenlik Çalışması, sorumlu araştırıcı,
6. REACH THEM; Demir birikiminde şelasyon tedavisi, Gözlemsel çalışma, Sorumlu araştırıcı,
7. NN7008-3545 kodlu Hemofili A olgularında Pediatrik N8 (rFVIII) çalışması, sorumlu araştırıcı,
8. NN7008-3568 kodlu Hemofili A olgularında Pediatrik N8 (rFVIII) çalışması, sorumlu araştırıcı,
9. Recombinant Factor VIIa analog çalışması, sorumlu araştırıcı,
10. Efficacy of FEIBA for acute bleeding and surgical hemostasis in hemofilia A, sorumlu araştırıcı
11. Post HSCT (CICL670ATR04) Çalışması; Kök Hücre Transplantasyonu yapılan talasemi majorlu olgularda deferasirox ile şelasyon tedavisinin güvenlik ve etkinliği, Baş Araştırıcı.
12. LJ401-BT01, A multicenter,randomised, open-label,parallel-group study with LIPC-401 for the treatment of myokardial iron overload in adult patients with transfusion dependent beta thalassemia (2017- ).
13. A phase 3 adaptive study comparing the efficacy and safety of defibrotide vs best supportive care in the prevention of hepatic veno occlussive disease in adult and pediatric patients undergoing HSCT.
Yurt Dışı Eğitim ve Kurslar
1. Torino University, Italy, Clinical observer,
Pediatric Hematology Department – Thalassemia Division
Bone marrow Transplantation Unit, May-June 1992.
2. Royal Free Hospital and School of Medicine, Londra, England
Clinical observer, Hematology and Bone marrow Transplantation Unit,
Agoust – October 1997.
3. Working Party on Paediatric Diseases
European Group for Blood and Marrow Transplantation
Barcelona, 7-9 May 1998.
4. European School of Haematology
The Third ESH-EBMT Postgraduate Training Course on Blood and Bone Marrow
Transplantation Potsdam,
Berlin, 6-9 June 1998.
5. European School of Haematology
The Eighth European Tutorial on Haematopathology
Londra, 6-10 March 1999.
6. European Council for Accreditation in Hematology
In association with the European School of Hematology
Advenced ICAS-Training Course on Blood Stem Transplantation: State-of-the-Arts,
Methods, and Perspectives, Ulm, 10-13, March, 2003.
7. European School of Haematology
The Tenth ESH-EBMT Postgraduate Training Course on Blood and Bone Marrow
Transplantation
Warsaw, Poland, 24-28 May 2006.
Kurduğu Lisansüstü Eğitim Programı
1. Kalıtsal Kan Hastalıkları Yüksek Lisans programı
    Akdeniz Üniversitesi Tıp Fakültesi Sağlık Bilimleri Enstitüsü
Verdiği lisans ve lisansüstü düzeydeki dersler
Akademik
Yıl
Dönem Dersin Adı Teorik
Saat
Uygulama
Saat
Öğrenci
Sayısı
2015-2016 Güz Dönem 2
Pediatri pratik uygulamaları

-

30

23
2015-2016 İlkbahar Dönem 2
Pediatri pratik uygulamaları

-

30

23
2016-2017 Güz Dönem 3
Propödetik Uygulamaları
Pediatrik Hematoloji Dersleri

-
8

30
-

23
23
2016-2017 İlkbahar Dönem 3
Propödetik Uygulamaları
Pediatrik Hematoloji Dersleri

-
8

30
-

23
23
Kitap Bölümleri
1. Pediatri’de Kök Hücre Transplantasyonu ve Etik
VI. Bölüm: Beta Talasemili Hastalarda Kök Hücre Transplantasyonu
2. Eritrosit Hastalıkları Tanı ve Tedavi El Kitabı
Editör ve “Eritrosit Metabolizma Bozuklukları” bölüm yazarlığı
3. Çocuk Hastalıkları (Textbook) – Türkiye Milli Pediatri Derneği
Bölüm: Anemiler
4. Pediatrik Hematoloji (Textbook)-Türk Pediatrik Hematoloji Derneği
Editör, “Hemolitik Anemiler” bölümü
5. Yurdakök Pediatri (Textbook) – Hematoloji Bölüm Editörü
Dergi Editörlüğü, Yayın Kurulu üyeliği, hakemlik
1. ASH 2012 (The 54th Annual Meeting of American Society of Hematology) abstract reviewer (Blood) ve sözel bildiriler oturum başkanlığı.
2. European Bone Marrow Transplantation (EBMT) 2015, Organizasyon komitesi üyeliği, Abstract reviewer ve Panel oturum başkanlığı.
3. Pediatrics, hakemlik
4. Pediatric Transplantation, hakemlik
5. Acta Hematologica, hakemlik
6. European Journal of Hematology, hakemlik
7. Archives of Medical Research, hakemlik
8. Frontiers in Medicine, hakemlik
9. Turkish Journal of Hematology, hakemlik
10. Turkish Journal of Pediatrics, Yayın Kurulu üyeliği
11. Çocuk Sağlığı ve Hastalıkları Dergisi, Yayın Kurulu üyeliği
12. Türk Çocuk Hematoloji Dergisi, Yayın Kurulu üyeliği
13. Türkiye Klinikleri Dergisi Pediatrik Hematoloji Editörlüğü
ESERLER
1.YEŞİLİPEK M.AKİF , Standart and Low Birth Weight Formula Compared for Effects on Growth of Preterm Infants, The Turkish Journal of Pediatrics, 34:31-36, 1992.
2. YEŞİLİPEK M.AKİF, LÜLECİ GÜVEN, OYGÜR NİHAL , BERKER SİBEL , YEĞİN OLCAY. A case of Juvenile Chronic Myeloid Leukemia with XX/XXX Mosoicism, The Turkish Journal of Pediatrics, 34:251-254,1992.
3. YEŞİLİPEK M.AKİF ,BİRCAN İFFET , OYGÜR NİHAL, ERTUĞ HALİL , YEĞİN OLCAY , GÜR GÜVEN AYFER. Growth and Sexual Maturation in Children with Beta Thalassemia Major, Haematologica , 78:30-33 , 1993.
4.YEŞİLİPEK M.AKİF, LÜLECİ GÜVEN, VELİPAŞAOĞLU SEVTAP, BERKER SİBEL, YEĞİN OLCAY. Monosomy 7 Myelodysplasia in childhood, Acta Haematologica 92: 36-38, 1994.
5.YEŞİLİPEK M.AKİF, KARADOĞAN İHSAN, ÜNDAR LEVENT. "Bernard-Soulier Syndrome: A Flow cytometric analysis of the membrane GP-Ib expression" , The Turkish Journal of Pediatrics, 38: 375-379, 1996.
6.YEŞİLİPEK M.AKİF, YEĞİN OLCAY. Interferon Alfa Therapy for Refractory Idiopathic Thrombocytopenic Purpura in Children , The Turkish Journal of Pediatrics, 39: 173-176, 1997.
7. YEŞİLİPEK M.AKİF, HAZAR VOLKAN, YEĞİN OLCAY. L-Carnitine treatment in beta thalassemia major, Acta Haematologica , 100:162-163, 1998.
8. HAZAR VOLKAN, ONGUN HAKAN, YEŞİLİPEK M.AKİF, YEĞİN OLCAY. Failure of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor in a Patient with Kostmann Syndrome, The Turkish Journal of Pediatrics, 41: 117-120, 1999.
9. YEŞİLİPEK M.AKİF, HAZAR VOLKAN, KÜPESİZ ALPHAN, YEĞİN OLCAY. Peripheral Stem Cell Transplantation in a Child with Amegakaryocytic Thrombocytopenia, Bone Marrow Transplant, 26 (5) : 569-70, 2000.
10. AKMAN S., BAHAT E., YEŞİLİPEK A., GÜR GÜVEN A. An uncommon cause of hematuria : Factor VII deficiency in two brothers. Pediatric Nephrology 2000; 14: 68.
11. OYGÜR NİHAL, TUNGA MUSTAFA, MUMCU YELDA, YEŞİLİPEK M.AKİF, GURA AŞKIN, COŞKUN MESUT, YEĞİN OLCAY. Thrombopoietin levels of thrombocytopenic term and preterm newborns with infection, Am J Perinatol, Aug;18(5): 279-86, 2001.
12. YEŞİLİPEK M.AKİF, HAZAR VOLKAN, KÜPESİZ ALPHAN, KIZILÖRS AYTUĞ, UĞUZ AYŞEN, YEĞİN OLCAY. Peripheral blood stem cell transplantation in children with beta thalassemia. Bone Marrow Transplant, 28 (11): 1037-40, 2001.
13. KESER I., GÜZELOĞLU-KAYIŞLI Ö., YEŞİLİPEK A., ÖZEŞ O.N., LÜLECİ G. Hb Antalya  Codons 3-5 ( Leu-Thr-ProSer-Asp-Ser).. A new unstable variant leading to chronic macrocytic anemia and high HbA2. Hemoglobin 25(4) : 369-373,2001.
14. BİRBEN E., ÖNER C., ÖNER R., MERGEN H., YEŞİLİPEK M.A., GÜMRÜK F., GÜRGEY A., ALTAY Ç. Severe β Thalassemia in frameshift Codon 6 (-A) Homozygotes: Effects of haplotype on phenotype. Hemoglobin 25(4): 441-445, 2001.
15. KARAUZUM SB, HAZAR V, AÇIKBAŞ I, GELEN T, YEŞİLİPEK MA, LULECİ G. Existence of acute lymphoblastic leukemia and osteosarcoma in a child, J Pediat Hematol Onc 24 (7): 572-574 OCT 2002.
16. HAZAR V, KANSOY S, KUPESIZ A, AKSOYLAR S, KANTAR M, YEŞİLİPEK A. High dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral stem cell transplantation. Bone Marrow Transplant 33: 931-935, 2004.
17. KESER I., SANLIOGLU A.D., MANGUOGLU E., GUZELOGLU KAYISLI O., NAL N., SARGIN F., YESILIPEK A., SIMSEK M., MENDILCIOGLU I., CANATAN D., LULECI G. Moleculer Analysis of Beta-Thalassemia in Antalya. Acta Haematologica, 111:205-210, 2004.
18. V.HAZAR, Z.BERBER, E.PEŞTERELI, M.COŞKUN, A.YEŞILIPEK, G.KARPUZOĞLU, O.YEGIN. Clinical importance of circulating and cellular expression levels of Fas and Fas ligand in pediatric patients with lymphoproliferative malignancies. Pediatric Hematology and Oncology, 22: 247-256, 2005.
19. G.TEZCAN, A.KÜPESIZ, A.YEŞILIPEK, V.HAZAR, GD AKSU, C.ÖZKAYNAK, G.ÖZBILIM. Embryonic rhabdomyosarcoma presenting as endobronchial tumor in an adolescent. Pediatric Blood and Cancer, 44, 689-690, 2005.
20. Z.ÇETIN, S.BERKER KARAÜZÜM, A.KÜPESIZ, V.HAZAR, M.A. YEŞILIPEK, G.LÜLECI. Lethal AML after stem cell transplantation in a child with DEB unresponsive Fanconi anemia. Haema,8.136-139, 2005.
21. Ö.GÜZELOGLU-KAYIŞLI, İ.KESER, O.N.ÖZEŞ, D.CANATAN, A.YEŞILIPEK, G.LÜLECI. Compound heterozygosity for two beta chain variants: the mildly unstable Hb Tyne (codon 5 Pro--- Ser) and HbS (codon 6 Glu--Val) . Turk J Haematol, 22.37-40, 2005.
22. SARGIN CF, NAL N, MANGUOGLU AE, KESER I, MENDILCIOGLU I, YESILIPEK A, LULECI G. The phenotypic effect of Hb G-Coushatta [beta22 (B4) Glu-Ala] and association with IVS. II.1(G-A)inaTurkishfamily. Genet Couns. 2005;16(3):307-8.
23. N.NAL, A.E.MANGUOGLU, C.F. SARGIN, İ.KESER, A. KÜPESIZ, A.YEŞILIPEK, G.LÜLECI. Two rare mutations in Turkey: IVS.130 (G-C) and IVS 848 (C-A). Clinical and Laboratory Hematology, 27.274-277, 2005.
24. HAZAR V, UGUR A, COLAK D, SABA R, TEZCAN G, KUPESIZ A, KARADOGAN I, GULTEKIN M, YESILIPEK A, UNDAR L. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovirtreatment. Jpn J Infect Dis. 2006 Aug;59(4):216-21.
25. TOPTAS B, BAYKAL A, YESILIPEK A, ISBIR M, KUPESIZ A, YALCIN O, BASKURT OK. L-carnitine deficiency and red blood cell mechanical impairment in beta-thalassemia major. Clin Hemorheol Microcirc. 2006;35(3):349-57.
26. TEZCAN G, KUPESIZ A, OZTURK F, OGUNC D, GULTEKIN M, YESILIPEK A, HAZAR V. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey. Pediatr Hematol Oncol. 2006 Apr-May;23(3):217-29.
27.CETIN Z, TEZCAN G, KARAUZUM SB, KUPESIZ A, MANGUOGLU A E, YESILIPEK A, LULECI G, HAZAR V. Donor Cell-derived Acute Myeloblastic Leukemia After Allogeneic Peripheral Blood Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia. J Pediatr Hematol Oncol. 2006 Nov;28(11):763-767.
28. YESILIPEK MA. Stem cell transplantation in hemoglobinopathies. Hemoglobin 2007;31(2):251-6.
29. KESER I, MANGUOGLU E, KAYİSLİ O, YESİLİPEK A, LULECİ G. Combination of Hb Knossos [Cod 27 (G-T)] and IVSII-745 (C-G) in a Turkish patient with beta-thalassemia major. Genet Test. 2007 Fall;11(3):228-30.
30. DUNDAR U, KUPESİZ A, OZDEM S, GİLGİL E, TUNCER T, YESİLİPEK A, GULTEKİN M. Bone metabolism and mineral density in patients with beta-thalassemia major. Saudi Med J. 2007 Sep;28(9):1425-9.
31. ARTAC H, COSKUN M, KARADOGAN I, YEGIN O, YESILIPEK A. Transferrin receptor in proliferation of T lymphocytes in infants with iron deficiency. International Journal Of Laboratory Hematology 29 (4): 310-315 Aug 2007.
32. GUVEN AG, HAZAR V, GUNGOR F, AG O, AKBAS H, TEZCAN G, AKMAN S, YESILIPEK A. Measurement of renal function with three methods in children undergoing bone marrow transplantation: is cystatin C useable? Pediatric Nephrology 22 (9): 1543-1543 Sep 2007.
33.OZDEM S, KUPESIZ A, YESILIPEK A. Plasma Homocysteine Levels In Patients With Beta-Thalassemia Major. Scand J Clin Lab Invest. 2008;68(2):134-9.
34. KARDELEN F, TEZCAN G, AKCURIN G, ERTUG H, YESILIPEK A. Heart rate variability in patients with thalassemia major. Pediatr Cardiol. 2008 Sep;29(5):935-9. Epub 2008 Jun 13.
35. YESİLİPEK MA, TEZCAN G, GERMESHAUSEN M, KUPESİZ A, UYGUN V, HAZAR V. Unrelated cord blood transplantation in children with severe congenital neutropenia. Pediatr Transplant. 2008 Sep 26.
36. HAZAR V, GUNGOR O, GUVEN AG, AYDİN F, AKBAS H, GUNGOR F, TEZCAN G, AKMAN S, YESİLİPEK A. Renal function after hematopoietic stem cell transplantation in children. Pediatr Blood Cancer. 2009 Aug;53(2):197-202.
37. AKAY A, DRAGOMIR A, YARDIMCI A, CANATAN D, YESILIPEK A, POGUE B. A Data-Mining Approach for Investigating Social and Economic Geographical Dynamics of ss-thalassemia's Spread. IEEE Trans Inf Technol Biomed. 2009;13(5):774-780.
38. DURSUN O, ERIŞIR S, YEŞILIPEK A. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years. Turk J Pediatr. 2009 Jan-Feb;51(1):1-5.
39. UYGUN V, KARASU GT, OGUNC D, YESİLİPEK A, HAZAR V. Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: A randomized and open-label study. Pediatr Blood Cancer. 2009;53:610-614.
40. CESARO S, HİRSCH HH, FARACİ M, OWOC-LEMPACH J, BELTRAME A, TENDAS A, BALTADAKİS I, DALLE JH, KOC Y, TOPORSKİ J, STYCZYNSKİ J, YESİLİPEK MA, HEİNZ W, CANİGLİA M, RASCON J, FAUSER AA, MİCHALLET M, LOPEZ-CORRAL L, NEUBURGER S, TRİDELLO G, EİNSELE H; European Group for Blood and Marrow Transplantation. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect Dis. 2009 Jul 15;49(2):233-40.
41. DURSUN O, HAZAR V, KARASU GT, UYGUN V, TOSUN O, YESILIPEK A. Prognostic factors in pediatric cancer patients admitted to the pediatric intensive care unit. J Pediatr Hematol Oncol. 2009 Jul;31(7):481-4.
42. YESİLİPEK MA, KARASU GT, KUPESİZ A, UYGUN V, HAZAR V. Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation. J Pediatr Hematol Oncol. 2009 Jul;31(7):512-5.
43. KESER I, YESILIPEK A, CANATAN D, et al. Abnormal Hemoglobins Associated With The Beta-Globin Gene In Antalya Province, Turkey. Turkish Journal Of Medical Sciences 2010;40(1):127-131.
44. AYDIN F, TEZCAN G, GUNGOR, et al. Can serum cystatin C reflect the glomerular filtration rate accurately in pediatric patients under chemotherapeutic treatment? A comparative study with Tc-99m DTPA two-plasma sample method. NUCLEAR MEDICINE COMMUNICATIONS 2010;31 (4): 301-306.
45. KAVAKLI K, YESILIPEK A, ANTMEN B, et al. The value of early treatment in patients with haemophilia and inhibitors. HAEMOPHILIA 2010;16 (3): 487-494.
46. YESILIPEK M. A, KARASU G, KAZIK M, et al. Posttransplant Oral Iron-Chelatıng Therapy In Patients With Beta-Thalassemıa Major Pedıatrıc Hematology and Oncology 2010; 27;(5): 374-379.
47. HAZAR V, KARASU G, UYGUN V, AKCAN M, KÜPESİZ A, YESİLİPEK A. Childhood Acute Lymphoblastic Leukemia in Turkey: Factors Influencing Treatment and Outcome A Single Center Experience. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY 2010; 32(8) P: E317-E322.
48. YESİLİPEK MA, KARASU G, ERÇELEN N, UYGUN V, AKCAN M, KUPESİZ A, HAZAR V. Successful hematopoietic SCT from non-identical twins to two sisters with β-thalassemia major by using preimplantation genetic diagnosis and HLA typing. Bone Marrow Transplant. 2011 Dec;46(12):1581-2.
49. KARASU GT, YESİLİPEK MA, KARAUZUM SB, UYGUN V, MANGUOGLU E, KUPESİZ A, HAZAR V. The value of donor lymphocyte infusions in thalassemia patients at imminent risk of graft rejection following stem cell transplantation. Pediatr Blood Cancer. 2012 Mar;58(3):453-8.
50. ZÜLFİKAR B, AYDOGAN G, SALCİOGLU Z, et al; FEIBA Investigators Team. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey. Hemophilia, 2012, 18 (3) pp 383-91.
51. STYCZYNSKİ J, BALDUZZİ A, GİL L, LABOPİN M, HAMLADJİ RM, MARKTEL S, YESİLİPEK MA, FAGİOLİ F, EHLERT K, MATULOVA M, DALLE JH, WACHOWİAK J, MİANO M, MESSİNA C, DİAZ MA, VERMYLEN C, EYRİCH M, BADELL I, DREGER P, GOZDZİK J, HUTT D, RASCON J, DİNİ G, PETERS C; European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party. Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study. Blood. 2012 Mar 22;119(12):2935-42.
52. FERNANDES JF, ROCHA V, LABOPİN M, et al. Eurocord and Inborn Errors Working Party of European Group for Blood and Marrow Transplantation. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood? Blood. 2012 Mar 22;119(12):2949-55.
53. AYDİNOK Y, UNAL S, OYMAK Y, VERGİN C, TÜRKER ZD, YİLDİZ D, YESİLİPEK A. Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload. Eur J Haematol. 2012 May;88(5):431-8.
54. CETİN Z, YAKUT S, KARADOGAN I, KUPESİZ A, TİMURAGAOGLU A, SALİM O, TEZCAN G, ALANOGLU G, OZBALCİ D, HAZAR V, YESİLİPEK MA, UNDAR L, LULECİ G, BERKER S. Aberrations of chromosomes 9 and 22 in acute lymphoblastic leukemia cases detected by ES-fluorescence in situ hybridization. Genet Test Mol Biomarkers. 2012 May;16(5):318-23.
55. DE PAULA EV, KAVAKLİ K, MAHLANGU J, ET AL. 1804 (ADEPT(TM)1) INVESTİGATORS. Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial. J Thromb Haemost. 2012 Jan;10(1):81-9.
56. UYGUN V, TAYFUN F, AKCAN M, KARASU GT, KUPESİZ A, HAZAR V, YEŞİLİPEK A. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients. Pediatr Hematol Oncol. 2012 Aug;29(5):461-71.
57. YESİLİPEK AM, AKCAN M, KARASU G, UYGUN V, KUPESİZ A, HAZAR V. Successful unrelated bone marrow transplantation in two siblings with alpha-mannosidosis. Pediatr Transplant. 2012 Nov;16(7):779-82.
58. EFE E, IŞLER A, SARVAN S, BAŞER H, YEŞİLİPEK A. Complementary and alternative medicine use in children with thalassaemia. J Clin Nurs. 2012 Aug 21.
59. YESİLİPEK MA, ERTEM M, CETİN M, ÖNİZ H, KANSOY S, TANYELİ A, ANAK S, KUREKCİ E, HAZAR V. HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group. Pediatr Transplant. 2012 Dec;16(8):846-51.
60. POWELL J, MARTİNOWİTZ U, WİNDYGA J, ET AL; LIPLONG STUDY INVESTİGATORS. Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study. Thromb Haemost. 2012 Nov;108(5):913-22.
61. DAİKELER T, LABOPİN M, RUGGERİ A, CROTTA A, ABİNUN M, HUSSEİN AA, CARLSON K, CORNİLLON J, DİEZ-MARTİN JL, GANDEMER V, FARACİ M, LİNDEMANS C, O'MEARA A, MİALOU V, RENARD M, SEDLACEK P, SİRVENT A, SOCİÉ G, SORA F, VAROTTO S, SANZ J, VOSWİNKEL J, VORA A, YESİLİPEK MA, HERR AL, GLUCKMAN E, FARGE D, ROCHA V. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of EBMT. Blood. 2013 Feb 7;121(6):1059-64.
62.ROVÓ A, ALJURF M, CHİODİ S, et al; Late Effects Working Party of the EBMT. Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2013 Mar;98(3):339-45.
63.KOCABAŞ A, KARDELEN F, ERTUĞ H, ALDEMİR-KOCABAŞ B, TOSUN Ö, YEŞİLİPEK A, HAZAR V, AKÇURİN G. Assessment of early-onset chronic progressive anthracycline cardiotoxicity in children: different response patterns of right and left ventricles. Pediatr Cardiol. 2014 Jan;35(1):82-8.
64. ELALFY M, WALİ YA, QARİ M, AL DAMANHOURİ G, AL-TONBARY Y, YAZMAN D, AL HAWSAWİ Z, KARAKAS Z, KİLİNC Y, YESİLİPEK MA, BADR M, ELSAFY U, SALAMA M, ABDEL RAHMAN Y, SHEBL S, STİLMAN A, TOİBER TEMİN N, TRİCTA F. Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis. Pediatr Blood Cancer. 2014 May;61(5):879-84.
65. PENNELL DJ, PORTER JB, PİGA A, LAİ Y, EL-BESHLAWY A, BELHOUL KM, ELALFY M, YESİLİPEK A, KİLİNÇ Y, LAWNİCZEK T, HABR D, WEİSSKOPF M, ZHANG Y, AYDİNOK Y. CORDELIA study investigators. A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA). Blood. 2014 Mar 6;123(10):1447-54.
66. SAYAR E, UYGUN DF, ISLEK A, HAZAR-SAYAR E, AKKAYA B, VİGNOLİ M, GAMBİNERİ E, YESİLİPEK MA, ARTAN R. Langerhans cell histiocytosis in IPEX syndrome: Possible role for natural regulatory T cells? Pediatr Allergy Immunol. 2014 Mar 16.
67. LALEZARİ S, COPPOLA A, LİN J, ENRİQUEZ MM, TSENEKLİDOU-STOETER D, POWELL J, INGERSLEV J; LIPLONG Investigators. Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study. Haemophilia. 2014 May;20(3):354-61.
68. ALDEMİR-KOCABAŞ B, TEZCAN-KARASU G, BİRCAN I, BİRCAN O, AKTAŞ-SAMUR A, YEŞİLİPEK MA. Evaluating the Patients with Thalassemia Major for Long-Term Endocrinological Complications After Bone Marrow Transplantation. Pediatr Hematol Oncol. 2014 Oct;31(7):616-23.
69. KAHRAMAN S, BEYAZYUREK C, YESİLİPEK MA, OZTURK G, ERTEM M, ANAK S, KANSOY S, AKSOYLAR S, KUŞKONMAZ B, ONİZ H, SLAVİN S, KARAKAS Z, TAC HA, GULUM N, EKMEKCİ GC. Successful haematopoietic stem cell transplantation in 44 children from healthy siblings conceived after preimplantation HLA matching. Reprod Biomed Online. 2014 Sep;29(3):340-51.
70. YILDIRIM AT, GÜNEŞ BT, OYMAK Y, YAMAN Y, OZEK G, CART O, YEŞİLİPEK A, VERGİN C. Congenital amegakaryocytic thrombocytopenia: three case reports from patients with different clinical diagnoses and somatic abnormalities. Blood Coagul Fibrinolysis. 2015 Apr;26(3):337-41.
71. UYGUN V, DALOGLU H, KARASU G, YEŞİLİPEK A. Photopheresis long after the initiation of chronic graft versus host in a child. Transfus Apher Sci. 2014;51(2):172-4.
72. YEŞİLİPEK MA. Hematopoetic stem cell transplantation in children. Turk Pediatri Ars. 2014 Jun 1;49(2):91-8.
73. KAVAKLİ K, YANG R, RUSEN L, BECKMANN H, TSENEKLİDOU-STOETER D, MAAS ENRİQUEZ M; LEOPOLD II STUDY INVESTİGATORS. Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II). J Thromb Haemost. 2015 Mar;13(3):360-9.
74. TUCUNDUVA L, VOLT F, CUNHA R, LOCATELLİ F, ZECCA M, YESİLİPEK A, CANİGLİA M, GÜNGÖR T, AKSOYLAR S, FAGİOLİ F, BERTRAND Y, ADDARİ MC, DE LA FUENTE J, WİNİARSKİ J, BİONDİ A, SENGELOEV H, BADELL I, MELLGREN K, DE HEREDİA CD, SEDLACEK P, VORA A, ROCHA V, RUGGERİ A, GLUCKMAN E; EUROCORD AND THE EBMT PAEDİATRİC WORKİNG PARTY. Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases. Br J Haematol. 2015 Apr;169(1):103-10.
75. CELMELİ F, TURKKAHRAMAN D, UYGUN V, LA MARCA G, HERSHFİELD M, YESİLİPEK A. A successful unrelated peripheral blood stem cell transplantation with reduced intensity-conditioning regimen in a patient with late-onset purine nucleoside phosphorylase deficiency. Pediatr Transplant. 2015 Mar;19(2):E47-50.
76. AYDİNOK Y, PORTER JB, PİGA A, ELALFY M, EL-BESHLAWY A, KİLİNÇ Y, VİPRAKASİT V, YESİLİPEK A, HABR D, QUEBE-FEHLİNG E, PENNELL DJ. Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study. Eur J Haematol. 2015 Sep;95(3):244-53.
77. PENNELL DJ, PORTER JB, PİGA A, LAİ YR, EL-BESHLAWY A, ELALFY M, YESİLİPEK A, KİLİNÇ Y, HABR D, MUSALLAM KM, SHEN J, AYDİNOK Y. CORDELIA study investigators. Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine. Am J Hematol. 2015 Feb;90(2):91-6.
78. UYGUN V, DALOGLU H, KARASU G, HAZAR V, YEŞİLİPEK A. Safety and Outcomes of Extracorporeal Photopheresis With the Therakos Cellex System for Graft-Versus-Host Disease in Pediatric Patients. J Pediatr Hematol Oncol. 2015;37(3):209-14.
79. UYGUN V, KARASU G, DALOĞLU H, HAZAR V, YEŞİLİPEK A. Idiopathic hyperammonemia after hematopoietic stem cell transplantation: A case report. Pediatr Transplant. 2015; 19(4):E104-5.
80. HAZAR V, KESİK V, AKSOYLAR S, KARAKUKCU M, OZTURK G, KUPESİZ A, ATAS E, ONİZ H, KANSOY S, UNAL E, TANYELİ A, ERBEY F, ELLİ M, TACYİLDİZ N, KARASU GT, KOCAK U, ANAK S, YİLMAZ BENGOA S, SEZGİN G, ATAY D, UNAL E, UYGUN V, KURUCU N, KAYA Z, YESİLİPEK A. Turkish Pediatric Bone Marrow Transplantation Study Group (TPBMT-SG).Outcome of autologous hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory Hodgkin's lymphoma. Pediatr Transplant. 2015;19(7):745-52.
81. FİOREDDA F, IACOBELLİ S, VAN BİEZEN A, GASPAR B, ANCLİFF P, DONADİEU J, ALJURF M, PETERS C, CALVİLLO M, MATTHES-MARTİN S, MORREALE G, VAN 'T VEER-TAZELAAR N, DE WREEDE L, AL SERAİHY A, YESİLİPEK A, FİSCHER A, BİERİNGS M, OZTURK G, SMİTH O, VEYS P, LJUNGMAN P, PEFFAULT DE LATOUR R, SÁNCHEZ DE TOLEDO CODİNA J, OR R, GANSER A, AFANASYEV B, WYNN R, KALWAK K, MARSH J, DUFOUR C; Severe Aplastic Anemia the Inborn Error, and the Pediatric Disease Working Parties of the European Society for Blood and Bone Marrow Transplantation (EBMT) and Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE). Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation.Blood. 2015 Oct 15;126(16):1885-92; quiz 1970.
82. YESİLİPEK MA, UYGUN V, KARASU G, DALOGLU H, DİNCER Z. Haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide in high-risk children: A single-center study. Pediatr Transplant. 2016;20(3):417-23.
83. KESİK V, ATAŞ E, KARAKÜKCÜ M, AKSOYLAR S, ERBEY F, TAÇYILDIZ N, KÜPESİZ A, ÖNİZ H, ÜNAL E, KANSOY S, ÖZTÜRK G, ELLİ M, KAYA Z, ÜNAL E, HAZAR V, YILMAZ BENGOA Ş, KARASU G, ATAY D, DAĞDEMİR A, ÖREN H, KOÇAK Ü, YEŞİLİPEK MA. Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin's Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group. Turk J Haematol. 2016;33(4):265-272.
84. UYGUN V, DALOĞLU H, ÖZTÜRKMEN SI, DÖŞEMECİ L, KARASU G, HAZAR V, YEŞİLİPEK A. Extracorporeal photopheresis did not prevent the development of an autoimmune disease: myasthenia gravis. Transfusion. 2016;56(12):3081-3085.
85. UYGUN V, UYGUN DF, DALOĞLU H, ÖZTÜRKMEN SI, KARASU G, HAZAR V, YEŞİLİPEK A. Outcomes of high-grade gastrointestinal graft-versus-host disease posthematopoietic stem cell transplantation in children. Medicine (Baltimore). 2016 Nov;95(44):e5242.
86. TEKGÜNDÜZ E, ŞENCAN İ, KAPUAĞASI A, ÜNAL D, ÖZTÜRK M, GÜMÜŞ E, GÖKER H, TAVİL EB, ERTEM M, ÇETİN M, ARAT M, SOYSAL T, KARAKAŞLI O, SUR HY, YEŞİLİPEK A, FERHANOĞLU B, UÇKAN D, İLHAN O, ALTUNTAŞ F. Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates. Transfus Apher Sci. 2016 Feb;54(1):53-9.
87. BARONCİANİ D, ANGELUCCİ E, POTSCHGER U, GAZİEV J, YESİLİPEK A, ZECCA M, OROFİNO MG, GİARDİNİ C, AL-AHMARİ A, MARKTEL S, DE LA FUENTE J, GHAVAMZADEH A, HUSSEİN AA, TARGHETTA C, PİLO F, LOCATELLİ F, DİNİ G, BADER P, PETERS C. HEMOPOİETİC STEM CELL TRANSPLANTATİON İN THALASSEMİA: A REPORT FROM THE EUROPEAN SOCİETY FOR BLOOD AND BONE MARROW TRANSPLANTATİON HEMOGLOBİNOPATHY REGİSTRY, 2000-2010. Bone Marrow Transplant. 2016 Apr;51(4):536-41.
88. BİLGEN T, ALTIOK CLARK Ö, ÖZTÜRK Z, YEŞİLİPEK MA, KESER İ. Gap-PCR Screening for Common Large Deletional Mutations of β-Globin Gene Cluster Revealed a Higher Prevalence of the Turkish Inversion/Deletion (δβ)0 Mutation in Antalya. Turk J Haematol. 2016 Jun 5;33(2):107-11.
89. TÜFEKÇİ Ö, KOÇAK Ü, KAYA Z, YENİCESU İ, ALBAYRAK C, ALBAYRAK D, YILMAZ BENGOA Ş, PATIROĞLU T, KARAKÜKÇÜ M, ÜNAL E, ÜNAL İNCE E, İLERİ T, ERTEM M, CELKAN T, ÖZDEMİR GN, SARPER N, KAÇAR D, YARALI N, ÖZBEK NY, KÜPESİZ A, KARAPINAR T, VERGİN C, ÇALIŞKAN Ü, TOKGÖZ H, SEZGİN EVİM M, BAYTAN B, GÜNEŞ AM, YILMAZ KARAPINAR D, KARAMAN S, UYGUN V, KARASU G, YEŞİLİPEK MA, KOÇ A, ERDURAN E, ATABAY B, ÖNİZ H, ÖREN H. Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients. Turk J Haematol. 2018 Mar 1;35(1):27-34.
90. HAZAR V, KESİK V, KARASU GT, ÖZTÜRK G, KÜPESİZ A, KILIÇ SÇ, ATAŞ E, UYGUN V, EKER N, ERBEY F, BENGOA ŞY, EMİR S, ANAK S, ÖNİZ H, DALOĞLU H, AKSOYLAR S, KOÇAK Ü, KARAKÜKÇÜ M, ELLİ M, KURUCU N, YEŞİLİPEK A. Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry. Leuk Lymphoma 2017 Jun 2:1-12.
91. KUREKCİ E, KÜPESİZ A, ANAK S, ÖZTÜRK G, GÜRSEL O, AKSOYLAR S, ILERİ T, KUŞKONMAZ B, EKER İ, CETİN M, TEZCAN KARASU G, KAYA Z, FIŞGIN T, ERTEM M, KANSOY S, YEŞİLİPEK MA. Hematopoietic Stem Cell Transplantation Using Preimplantation Genetic Diagnosis and Human Leukocyte Antigen Typing for Human Leukocyte Antigen-Matched Sibling Donor: A Turkish Multicenter Study. Biol Blood Marrow Transplant. 2017 May;23(5):790-794.
92. AYDINOK Y, OYMAK Y, ATABAY B, AYDOĞAN G, YEŞİLİPEK A, ÜNAL S, KILINÇ Y, OFLAZ B, AKIN M, VERGİN C, SEZGİN EVİM M, ÇALIŞKAN Ü, ÜNAL Ş, BAY A, KAZANCI E, İLERİ DT, ATAY D, PATIROĞLU T, KAHRAMAN S, SÖKER M, AKCAN M, AKDENİZ A, BÜYÜKAVCI M, ALANOĞLU G, BÖR Ö, SOYER N, ÖZDEMİR KARADAŞ N, UYSALOL E, TÜRKER M, AKÇAY A, OCAK S, GÜNEŞ AM, TOKGÖZ H, UYSAL Z, TİFTİK N, KARAKAŞ Z. A national registry of thalassemia in Turkey; demographic and disease characteristics of patients, achievements and challenges in prevention. Turk J Haematol. 2017 Apr 13. doi: 10.4274/tjh.2017.0039. [Epub ahead of print]
93. DALLE JH, LUCCHİNİ G, BALDUZZİ A, IFVERSEN M, JAHNUKAİNEN K, MACKLON KT, AHLER A, JARİSCH A, ANSARİ M, BEOHOU E, BRESTERS D, CORBACİOGLU S, DALİSSİER A, DİAZ DE HEREDİA RUBİO C, DİESCH T, GİBSON B, KLİNGEBİEL T, LANKESTER A, LAWİTSCHKA A, MOFFAT R, PETERS C, POİROT C, SAENGER N, SEDLACEK P, TRİGOSO E, VETTENRANTA K, WACHOWİAK J, WİLLASCH A, VON WOLFF M, YANİV I, YESİLİPEK A, BADER P. State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29-30 September 2015. Bone Marrow Transplant. 2017 Jul;52(7):1029-1035.
94. UYGUN V, DALOGLU H, ÖZTÜRKMEN S, KARASU G, YESİLİPEK A. Three relapses after a haploidentical transplantation in a pediatric patient: Cure with no further transplantation. Pediatr Transplant. 2017 Sep;21(6).
95. BALDUZZİ A, DALLE JH, JAHNUKAİNEN K, VON WOLFF M, LUCCHİNİ G, IFVERSEN M, MACKLON KT, POİROT C, DİESCH T, JARİSCH A, BRESTERS D, YANİV I, GİBSON B, WİLLASCH AM, FADİNİ R, FERRARİ L, LAWİTSCHKA A, AHLER A, SÄNGER N, CORBACİOGLU S, ANSARİ M, MOFFAT R, DALİSSİER A, BEOHOU E, SEDLACEK P, LANKESTER A, DE HEREDİA RUBİO CD, VETTENRANTA K, WACHOWİAK J, YESİLİPEK A, TRİGOSO E, KLİNGEBİEL T, PETERS C, BADER P. Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group. Bone Marrow Transplant. 2017 Oct;52(10):1406-1415.
96. UYGUN DFK, UYGUN V, REİSLİ İ, KELEŞ S, ÖZEN A, YILMAZ M, SAYAR EH, DALOĞLU H, ÖZTÜRKMEN SI, ÇAKI S, KARASU GT, YEŞİLİPEK A. Hematopoietic stem cell transplantation from unrelated donors in children with DOCK8 deficiency. Pediatr Transplant. 2017 Nov;21(7).
97. KARASU G, UYGUN V, YESİLİPEK A. Factors associated with peripheral blood stem cell yield in healthy pediatric donors. Transfus Apher Sci. 2017 Dec;56(6):819-824.
98. HAZAR V, KESİK V, KARASU GT, ÖZTÜRK G, KÜPESİZ A, KILIÇ SÇ, ATAŞ E, UYGUN V, EKER N, ERBEY F, BENGOA ŞY, EMİR S, ANAK S, ÖNİZ H, DALOĞLU H, AKSOYLAR S, KOÇAK Ü, KARAKÜKÇÜ M, ELLİ M, KURUCU N, YEŞİLİPEK A. Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry. Leuk Lymphoma. 2018 Jan;59(1):85-96.
99. CORBACİOGLU S, CARRERAS E, ANSARİ M, BALDUZZİ A, CESARO S, DALLE JH, DİGNAN F, GİBSON B, GUENGOER T, GRUHN B, LANKESTER A, LOCATELLİ F, PAGLİUCA A, PETERS C, RİCHARDSON PG, SCHULZ AS, SEDLACEK P, STEİN J, SYKORA KW, TOPORSKİ J, TRİGOSO E, VETTERANTA K, WACHOWİAK J, WALLHULT E, WYNN R, YANİV I, YESİLİPEK A, MOHTY M, BADER P. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2018 Feb;53(2):138-145.
100. AYDINOK Y, OYMAK Y, ATABAY B, AYDOĞAN G, YEŞİLİPEK A, ÜNAL S, KILINÇ Y, OFLAZ B, AKIN M, VERGİN C, SEZGİN EVİM M, ÇALIŞKAN Ü, ÜNAL Ş, BAY A, KAZANCI E, İLERİ T, ATAY D, PATIROĞLU T, KAHRAMAN S, SÖKER M, AKCAN M, AKDENİZ A, BÜYÜKAVCI M, ALANOĞLU G, BÖR Ö, SOYER N, ÖZDEMİR KARADAŞ N, UYSALOL E, TÜRKER M, AKÇAY A, OCAK S, GÜNEŞ AM, TOKGÖZ H, ÜNAL E, TİFTİK N, KARAKAŞ Z. A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention. Turk J Haematol. 2018 Mar 1;35(1):12-18.
101. BARZAGHİ F, AMAYA HERNANDEZ LC, NEVEN B, RİCCİ S, KUCUK ZY, BLEESİNG JJ, NADEMİ Z, SLATTER MA, ULLOA ER, SHCHERBİNA A, ROPPELT A, WORTH A, SİLVA J, AİUTİ A, MURGUİA-FAVELA L, SPECKMANN C, CARNEİRO-SAMPAİO M, FERNANDES JF, BARİS S, OZEN A, KARAKOC-AYDİNER E, KİYKİM A, SCHULZ A, STEİNMANN S, NOTARANGELO LD, GAMBİNERİ E, LİONETTİ P, SHEARER WT, FORBES LR, MARTİNEZ C, MOSHOUS D, BLANCHE S, FİSHER A, RUEMMELE FM, TİSSANDİER C, OUACHEE-CHARDİN M, RİEUX-LAUCAT F, CAVAZZANA M, QASİM W, LUCARELLİ B, ALBERT MH, KOBAYASHİ I, ALONSO L, DİAZ DE HEREDİA C, KANEGANE H, LAWİTSCHKA A, SEO JJ, GONZALEZ-VİCENT M, DİAZ MA, GOYAL RK, SAUER MG, YESİLİPEK A, KİM M, YİLMAZ-DEMİRDAG Y, BHATİA M, KHLEVNER J, RİCHMOND PADİLLA EJ, MARTİNO S, MONTİN D, NETH O, MOLİNOS-QUİNTANA A, VALVERDE-FERNANDEZ J, BROİDES A, PİNSK V, BALLAUF A, HAERYNCK F, BORDON V, DHOOGE C, GARCİA-LLORET ML, BREDİUS RG, KAŁWAK K, HADDAD E, SEİDEL MG, DUCKERS G, PAİ SY, DVORAK CC, EHL S, LOCATELLİ F, GOLDMAN F, GENNERY AR, COWAN MJ, RONCAROLO MG, BACCHETTA R; PRİMARY IMMUNE DEFİCİENCY TREATMENT CONSORTİUM (PIDTC) AND THE INBORN ERRORS WORKİNG PARTY (IEWP) OF THE EUROPEAN SOCİETY FOR BLOOD AND MARROW TRANSPLANTATİON (EBMT). Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study. J Allergy Clin Immunol. 2018 Mar;141(3):1036-1049.
102. YESİLİPEK MA, KARASU G, KAYA Z, KUSKONMAZ BB, UYGUN V, DAG I, OZUDOGRU O, ERTEM M. A Phase II, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major. Biol Blood Marrow Transplant. 2018 Mar;24(3):613-618.
103. KOCACİK UYGUN DF, UYGUN V, DALOĞLU H, ÖZTÜRKMEN SI, KARASU GT, HAZAR V, YEŞİLİPEK A. Immune Reconstitution Inflammatory Syndrome After DLI in a SCID Patient After Hematopoetic Stem Cell Transplantation. J Pediatr Hematol Oncol. 2018 Apr;40(3).
104. UYGUN V, DALOĞLU H, ÖZTÜRKMEN S, KARASU G, AVCI Z, YEŞİLİPEK A. Chronic neutrophilic leukemia, an extremely rare cause of neutrophilia in childhood: Cure with hematopoietic stem cell transplantation. Pediatr Transplant. 2018 Aug;22(5).
105. DALLE JH, BALDUZZİ A, BADER P, LANKESTER A, YANİV I, WACHOWİAK J, PİECZONKA A, BİERİNGS M, YESİLİPEK A, SEDLAÇEK P, IFVERSEN M, SUFLİARSKA S, TOPORSKİ J, GLOGOVA E, POETSCHGER U, PETERS C. Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes. Biol Blood Marrow Transplant. 2018 Sep;24(9):1848-1855.
106. KOCACİK UYGUN DF, UYGUN V, DALOĞLU H, ÖZTÜRKMEN S, KARASU G, REİSLİ İ, SAYAR E, YÜKSEKKAYA HA, GLOCKER EO, BOZTUĞ K, YEŞİLİPEK A. Hematopoietic Stem Cell Transplantation From Unrelated Donors in 2 Cases of Interleukin-10 Receptor Deficiency: Is Surgery Not a Requirement? J Pediatr Hematol Oncol. 2019 Jan;41(1):64-66.
107. HAZAR V, KARASU GT, UYGUN V, ÖZTÜRK G, KİLİÇ SÇ, KÜPESİZ A, DALOGLU H, AKSOYLAR S, ATAY D, INCE EÜ, KARAKÜKÇÜ M, ÖZBEK N, TAYFUN F, KANSOY S, ÖZYÜREK E, AKÇAY A, GÜRSEL O, HASKOLOGLU S, KAYA Z, YİLMAZ S, TANYELİ A, YESİLİPEK A. Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish Pediatric Bone Marrow Transplantation Study Group. Med Mycol. 2019 Feb 1;57(2):161-170.
108. ANTMEN B, KARAKAŞ Z, YEŞİLİPEK MA, KÜPESİZ OA, ŞAŞMAZ İ, UYGUN V, KURTOĞLU E, OKTAY G, AYDOGAN G, AKIN M, SALCİOGLU Z, VERGİN C, KAZANCI EG, ÜNAL S, ÇALIŞKAN Ü, ARAL YZ, TÜRKKAN E, MERAL GÜNEŞ A, TUNÇ B, GÜMRÜK F, AYHAN AC, SÖKER M, KOÇ A, OYMAK Y, ERTEM M, TİMUR Ç, YILDIRMAK Y, İRKEN G, APAK H, BİNER B, EREN TG, IŞIK BALCI Y, KOÇAK Ü, KARASU G, AKKAYNAK D, PATIROĞLU T. Deferasirox in children with transfusion-dependent thalassemia or sickle cell anemia: A large cohort real-life experience from Turkey (REACH-THEM). Eur J Haematol. 2019 Feb;102(2):123-130.
109. IKİNCİOGULLARİ A, CAGDAS D, DOGU F, TUGRUL T, KARASU G, HASKOLOGLU S, AKSOYLAR S, UYGUN V, KUPESİZ A, YİLDİRAN A, GURSEL O, ATES C, ELHAN A, KANSOY S, YESİLİPEK A, TEZCAN I; TURKİSH PEDİATRİC BONE MARROW TRANSPLANTATİON SUB GROUP (TPBMT-SG). Clinical Features and HSCT Outcome for SCID in Turkey. J Clin Immunol. 2019 Apr;39(3):316-323.
110. UYGUN V, KARASU G, DALOĞLU H, ÖZTÜRKMEN S, ÇAKI KILIÇ S, HAZAR V, YEŞİLİPEK A. Haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide in high-risk children: A single-center study. Pediatr Transplant. 2019 Jul 6:e13546.
111. BALDUZZİ A, DALLE JH, WACHOWİAK J, YANİV I, YESİLİPEK A, SEDLACEK P, BİERİNGS M, IFVERSEN M, SUFLİARSKA S, KALWAK K, LANKESTER A, TOPORSKİ J, MAİO LD, GLOGOVA E, POETSCHGER U, PETERS C. Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study. Biol Blood Marrow Transplant. 2019 Jul 15. pii: S1083-8791(19)30443-4. doi: 10.1016/j.bbmt.2019.07.011.
112. YILMAZ KARAPINAR D, PATIROĞLU T, METİN A, ÇALIŞKAN Ü, CELKAN T, YILMAZ B, KARAKAŞ Z, KARAPINAR TH, AKINCI B, ÖZKINAY F, ONAY H, YEŞİLİPEK MA, et al. Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry. Pediatr Blood Cancer. 2019 Oct;66(10):e27923. doi: 10.1002/pbc.27923.
113. UYGUN V, RUSSO R, KARASU G, DALOĞLU H, IOLASCON A, YEŞİLİPEK A. Hematopoietic Stem Cell Transplantation in Congenital Dyserythropetic Anemia Type II: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2019 Oct 4.
114. UYGUN V, KARASU G, DALOĞLU H, ÖZTÜRKMEN S, KILIÇ SÇ, YALÇIN K, ÇELEN SS, HAZAR V, YEŞİLİPEK A. Ruxolitinib salvage therapy is effective for steroid-refractory graft-versus-host disease in children: A single-center experience. Pediatr Blood Cancer. 2020 Apr;67(4): e28190.
115. NAVA T, ANSARİ M, DALLE JH, DE HEREDİA CD, GÜNGÖR T, TRİGOSO E, FALKENBERG U, BERTAİNA A, GİBSON B, JARİSCH A, BALDUZZİ A, BOENİG H, KRİVAN G, VETTENRANTA K, MATİC T, BUECHNER J, KALWAK K, LAWİTSCHKA A, YESİLİPEK A, et al. Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2020 Feb 6.
116. HAZAR V, KARASU GT, UYGUN V, ÖZBEK N, KARAKÜKÇÜ M, ÖZTÜRK G, DALOĞLU H, KILIÇ SÇ, AKSU T, ÜNAL E, KOÇAK Ü, YEŞİLİPEK A,et al. Role of a second transplantation for children with acute leukemia following posttransplantation relapse: a study by the Turkish Bone Marrow Transplantation Study Group. Leuk Lymphoma. Leuk Lymphoma. 2020 Jun;61(6):1465-1474. doi: 10.1080/10428194.2020.1716220. Epub 2020 Feb 8. PMID: 32037917
117. WİLLASCH AM, PETERS C, SEDLÁČEK P, DALLE JH, KİTRA-ROUSSOU V, YESİLİPEK A, et al, EBMT PAEDİATRİC DİSEASES WORKİNG PARTY. Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy? -A multicenter EBMT-PDWP study. Bone Marrow Transplant. 2020 Mar 17.
118. WILLASCH AM, PETERS C, SEDLÁČEK P, DALLE JH, KITRA-ROUSSOU V, YESILIPEK A, et al. Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy? -A multicenter EBMT-PDWP study. Bone Marrow Transplant. 2020 Aug;55(8):1540-1551. doi: 10.1038/s41409-020-0854-0. Epub 2020 Mar 17.
119. BALDUZZİ A, BÖNİG H, JARİSCH A, NAVA T, ANSARİ M, CATTONİ A, PRUNOTTO G, LUCCHİNİ G, KRİVAN G, MATİC T, KALWAK K, YESİLİPEK A., et al. ABO incompatibile graft management in pediatric transplantation. Bone Marrow Transplant. 2020 Jun 27. doi: 10.1038/s41409-020-0981-7. Online ahead of print.
120. YESİLİPEK MA. Hematopoietic Stem Cell Transplantation in Patients with Hemoglobinopathies. Hemoglobin. 2020 Oct 13:1-8. doi: 10.1080/03630269.2020.1832516. Online ahead of print.
121. YALCİN K, OVALİ E, OZDAMARLAR U, CELEN S, KARASU G, YESİLİPEK A, HAZAR V. NK-92 cellular therapy for pediatric relapsed/refractory Ewing sarcoma. Int Cancer Conf J. 2020 Mar 24;9(3):137-140. doi: 10.1007/s13691-020-00406-6. eCollection 2020 Jul.
122. UYGUN DFK, UYGUN V, KARASU GT, DALOĞLU H, ÖZTÜRKMEN SI, ÇELMELİ F, TÖRÜN SH, ÖZEN A, BARIŞ S, AYDINER EK, YALÇIN K, KILIÇ SÇ, HAZAR V, BİNGÖL A, YEŞİLİPEK A. Hematopoietic stem cell transplantation in CD40 ligand deficiency: A single-center experience. Pediatr Transplant. 2020 Sep;24(6):e13768. doi: 10.1111/petr.13768. Epub 2020 Jun 23.
123. UYGUN V, KARASU G, DALOĞLU H, ÖZTÜRKMEN S, YALÇIN K, ÇELEN SS, YEŞİLİPEK A. Use of low cell dose for unmanipulated donor lymphocyte for management of cytomegalovirus infection: A single-center experience. Pediatr Transplant. 2020 Oct 19;e13882. doi: 10.1111/petr.13882. Online ahead of print.
124. DE LA FUENTE J, GLUCKMAN E, MAKANİ J, TELFER P, FAULKNER L, CORBACİOGLU S, PERSİS AMROLİA, MARC ANSARİ, ADRİANA BALDUZZİ, ARNAUD DALASSİER, JEAN-HUGUES DALLE, CRİSTİNA HEREDA DİAZ, TOBİAS FEUCHTİNGER, FRANCO LOCATELLİ, GİOVANNA LUCCHİNİ, JAQUES-EMMANUEL GALİMARD, MARTA GONZALEZ VİNCENT, RUPERT HANDGRETİNGER, KATHARİNA KLEİNSCHMİDT, ANİTA LAWİTSCHKA, ANTONİO PEREZ MARTİNEZ, CHRİSTİNA PETERS, VANDERSON ROCHA, ANNALİSA RUGGERİ, PETR SEDLACEK, PETER SVEC, JACEK TOPORSKİ, AKİF YESİLİPEK ; Paediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation. The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing. Lancet Haematol. 2020 Dec;7(12):e902-e911. doi: 10.1016/S2352-3026(20)30283-0.
125. DALLE JH, BALDUZZİ A, BADER P, PİECZONKA A, YANİV I, LANKESTER A, BİERİNGS M, YESİLİPEK A, et al. The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG. Bone Marrow Transplant. 2020 Aug 4. doi: 10.1038/s41409-020-01014-x. Online ahead of print.
126. KÜPESİZ FT, HAZAR V, EKER N, GULER E, YESİLİPEK MA, TUYSUZ G, KUPESİZ A. Retrospective Evaluation of Relationship Between Iron Overload and Transplantation Complications in Pediatric Patient Who Underwent Allogeneic Stem Cell Transplantation Due to Acute Leukemia and Myelodysplastic Syndrome. J Pediatr Hematol Oncol. 2020 Jul;42(5):e315-e320. doi: 10.1097/MPH.0000000000001829.